These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27467156)

  • 1. A Risk Assessment Perspective of Current Practice in Characterizing Uncertainties in QSAR Regression Predictions.
    Sahlin U; Filipsson M; Öberg T
    Mol Inform; 2011 Jun; 30(6-7):551-64. PubMed ID: 27467156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncertainty in QSAR predictions.
    Sahlin U
    Altern Lab Anim; 2013 Mar; 41(1):111-25. PubMed ID: 23614548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Kernel-Based Method for Assessing Uncertainty on Individual QSAR Predictions.
    Tebby C; Mombelli E
    Mol Inform; 2012 Oct; 31(10):741-51. PubMed ID: 27476456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arguments for considering uncertainty in QSAR predictions in hazard and risk assessments.
    Sahlin U; Golsteijn L; Iqbal MS; Peijnenburg W
    Altern Lab Anim; 2013 Mar; 41(1):91-110. PubMed ID: 23614547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicability Domain Dependent Predictive Uncertainty in QSAR Regressions.
    Sahlin U; Jeliazkova N; Öberg T
    Mol Inform; 2014 Jan; 33(1):26-35. PubMed ID: 27485196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and description of the uncertainty, variability, bias and influence in quantitative structure-activity relationships (QSARs) for toxicity prediction.
    Cronin MTD; Richarz AN; Schultz TW
    Regul Toxicol Pharmacol; 2019 Aug; 106():90-104. PubMed ID: 31026540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two approaches to incorporate clinical data uncertainty into multiple criteria decision analysis for benefit-risk assessment of medicinal products.
    Wen S; Zhang L; Yang B
    Value Health; 2014 Jul; 17(5):619-28. PubMed ID: 25128056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian methodology for model uncertainty using model performance data.
    Droguett EL; Mosleh A
    Risk Anal; 2008 Oct; 28(5):1457-76. PubMed ID: 18793282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncertainty analysis based on probability bounds (p-box) approach in probabilistic safety assessment.
    Karanki DR; Kushwaha HS; Verma AK; Ajit S
    Risk Anal; 2009 May; 29(5):662-75. PubMed ID: 19302279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "This Is What We Don't Know": Treating Epistemic Uncertainty in Bayesian Networks for Risk Assessment.
    Sahlin U; Helle I; Perepolkin D
    Integr Environ Assess Manag; 2021 Jan; 17(1):221-232. PubMed ID: 33151017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting physical properties of emerging compounds with limited physical and chemical data: QSAR model uncertainty and applicability to military munitions.
    Bennett ER; Clausen J; Linkov E; Linkov I
    Chemosphere; 2009 Nov; 77(10):1412-8. PubMed ID: 19793608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of uncertainty in chemical models by Bayesian probabilities: Why, when, how?
    Sahlin U
    J Comput Aided Mol Des; 2015 Jul; 29(7):583-94. PubMed ID: 25491202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ensemble model of QSAR tools for regulatory risk assessment.
    Pradeep P; Povinelli RJ; White S; Merrill SJ
    J Cheminform; 2016; 8():48. PubMed ID: 28316646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species Sensitivity Distribution estimation from uncertain (QSAR-based) effects data.
    Aldenberg T; Rorije E
    Altern Lab Anim; 2013 Mar; 41(1):19-31. PubMed ID: 23614542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a unified probabilistic framework to the dose-response assessment of acrolein.
    Blessinger T; Davis A; Chiu WA; Stanek J; Woodall GM; Gift J; Thayer KA; Bussard D
    Environ Int; 2020 Oct; 143():105953. PubMed ID: 32768806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncertainty and precaution in European environmental risk assessment of chemicals.
    Verdonck FA; Van Sprang PA; Vanrolleghem PA
    Water Sci Technol; 2005; 52(6):227-34. PubMed ID: 16315366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the uncertainties in cancer risk assessment using the integrated probabilistic risk assessment (IPRA) approach.
    Slob W; Bakker MI; Biesebeek JD; Bokkers BG
    Risk Anal; 2014 Aug; 34(8):1401-22. PubMed ID: 24766324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internal and external validation of the long-term QSARs for neutral organics to fish from ECOSAR™.
    de Haas EM; Eikelboom T; Bouwman T
    SAR QSAR Environ Res; 2011; 22(5-6):545-59. PubMed ID: 21732893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explore a Multivariate Bayesian Uncertainty Processor driven by artificial neural networks for probabilistic PM
    Zhou Y; Chang LC; Chang FJ
    Sci Total Environ; 2020 Apr; 711():134792. PubMed ID: 31812407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of probabilistic exposure assessment and probabilistic hazard characterization.
    van der Voet H; Slob W
    Risk Anal; 2007 Apr; 27(2):351-71. PubMed ID: 17511703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.